Hypertrophic Cardiomyopathy
157
26
37
71
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
12 trials with published results (8%)
Research Maturity
71 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.5%
7 terminated out of 157 trials
91.0%
+4.5% vs benchmark
8%
12 trials in Phase 3/4
17%
12 of 71 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 71 completed trials
Clinical Trials (157)
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
Empagliflozin in Hypertrophic Cardiomyopathy
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM
Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous)
Effect of Personalized Accelerated Pacing in Symptomatic Patients With Non-Obstructive Hypertrophic Cardiomyopathy
A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy
Institutional Registry of Rare Diseases
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study
Austrian Hypertrophic Cardiomyopathy Registry
Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
A Trial of HRS-1893 in Healthy Volunteers
Mavacamten Pregnancy Surveillance Program
The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
Intraventricular Stasis In Cardiovascular Disease
Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition